Evolution of the Average Target: Exponent, Inc.

Evolution of the Target Price: Exponent, Inc.

Changes in Analyst Recommendations: Exponent, Inc.

e1043253f883c2382356b75346.WSoTufgW8t10P3Nopg-ALu9l3QCKWi4tOmdZg-8CTsY.HlBQjYJEsO4XRwMK4z7EG9sNrEzaaGVPSi1rupdGAYUjciPRqnSFiUxONg~cf4a9f433205bb1697555a7214e76834
01/05 UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating MT
09/02 UBS Lifts Price Target on Exponent to $85 From $81, Maintains Neutral Rating MT
26/01 JPMorgan Initiates Coverage on Exponent With Overweight Rating, $100 Price Target MT
17/11 William Blair Upgrades Exponent to Outperform From Market Perform MT
01/25/01 UBS Adjusts Price Target on Exponent to $76 From $84, Maintains Neutral Rating MT
25/24/25 UBS Adjusts Price Target on Exponent to $112 From $110, Maintains Neutral Rating MT
26/24/26 UBS Adjusts Exponent Price Target to $110 From $88, Maintains Neutral Rating MT
26/24/26 Truist Adjusts Price Target on Exponent to $120 From $100, Maintains Buy Rating MT
26/24/26 Truist Securities Adjusts Exponent's Price Target to $100 From $95, Keeps Buy Rating MT
31/23/31 Truist Securities Adjusts Exponent's Price Target to $110 From $120, Keeps Buy Rating MT
01/23/01 UBS Initiates Coverage on Exponent With Neutral Rating, $99 Price Target MT
01/22/01 Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors MT
06/22/06 Berenberg Bank Adjusts Exponent's' Price Target to $116 From $135, Maintains Buy Rating MT
05/22/05 Truist Securities Adjusts Exponent's Price Target to $120 From $115, Reiterates Buy Rating MT
01/21/01 Truist Securities Adjusts Exponent's Price Target to $126 From $118, Reiterates Buy Rating MT
08/21/08 EXPONENT : Berenberg Bank Boosts Price Target on Exponent to $135 From $112, Maintains Buy Rating MT
02/21/02 EXPONENT : Truist Securities Adjusts Exponent's Price Target to $118 From $110, Reiterates Buy Rating MT
24/21/24 EXPONENT : Berenberg Bank Adjusts Exponent PT to $112 From $95, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.8%
+23.97%
+10.59%
+27.23%
+21.26%
+0.93%
+7.06%
+7.97%
+19.67%
Average +17.72%
Weighted average by Cap. +18.95%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
58.00USD
Average target price
81.67USD
Spread / Average Target
+40.80%
High Price Target
90.00USD
Spread / Highest target
+55.17%
Low Price Target
75.00USD
Spread / Lowest Target
+29.31%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
JPMorgan Chase
William Blair & Co.
Truist Securities
Berenberg Bank
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
58.00USD
Average target price
81.67USD
Spread / Average Target
+40.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXPO Stock
  4. Consensus Exponent, Inc.